At Novo Nordisk, our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders.
Berlin-based startup LabTwin launched the first voice-powered lab assistant in 2019.
In our inaugural Startup Creasphere APAC program in Singapore, our corporate partners, Roche and Sanofi, delved into innovation topics in the healthcare sector across the Asia-Pacific region and shared their views on the future of healthcare.
Respiree from Singapore provides targeted predictions and diagnosis of cardio-respiratory diseases using a combination of advanced breath-cardio sensors and artificial intelligence.
Us.ai (former eko.ai) from Singapore wants to automate the fight against cardiovascular diseases with their solution that uses machine learning to automate the analysis of echocardiograms.
In June 30, 2020 the first virtual Expo Day for Batch 4 of Startup Creasphere took place. We are really delighted that over 400 people attended the live webcast.
Building on five successful batches in Munich, Startup Creasphere now expands its program to the APAC region.
Blumio, a startup from the San Francisco Bay Area and participant in Batch 3, has developed a health sensor to measure a person’s blood pressure continuously without an inflatable cuff.
Recent years have seen an exponential increase in the use of medication to treat chronic pain and associated disorders. Patient-directed music interventions have been shown to be directly linked to patient well-being.
Mesh Bio, based in Singapore and the first startup from Asia in our accelerator program.
